Pirenzepine
Back to searchMolecule Structure
Scientific Name
Pirenzepine
Description of the Drug
Pirenzepine is an antimuscarinic agent used to treat peptic ulcers, gastric ulcers, and duodenal ulcers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00670
http://www.drugbank.ca/drugs/DB00670
Brand Name(s)
Gastri p, Gastrozepin
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL41705 | |
| PharmGKB | PA10159 | |
| Human Metabolome Database | HMDB0014808 | |
| DrugBank | DB00670 | |
| PubChem: Thomson Pharma | 14852009 | |
| PubChem | 4848 | |
| LINCS | LSM-4001 | |
| Nikkaji | J20.030A | |
| BindingDB | 39341 | |
| EPA CompTox Dashboard | DTXSID7023487 | |
| DrugCentral | 2200 | |
| Brenda | 138750 | |
| Guide to Pharmacology | 328 | |
| rxnorm | PIRENZEPINE HYDROCHLORIDE | PIRENZEPINE |
| KEGG Ligand | C07508 | |
| ChEBI | 8247 | |
| ZINC | ZINC000019632927 |
